DANIEL J STARKS Insider Trading $ABT ABBOTT LABORATORIES
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL J STARKS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL J STARKS. DANIEL J STARKS is in ABBOTT LABORATORIES ($ABT) and Director in ABBOTT LABORATORIES ($ABT) and Chairman, CEO & President in ST JUDE MEDICAL INC ($STJ) and Director in ST JUDE MEDICAL INC ($STJ) and President and COO in ST JUDE MEDICAL INC ($STJ) and President, CEO & Chairman in ST JUDE MEDICAL INC ($STJ) and Director in UROLOGIX INC ($ULGX).
DANIEL J STARKS in ABBOTT LABORATORIES
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL J STARKS:
Holdings: 7,021,898 shares
Current Value: $301,169,205
Latest Transaction: Apr 27 2021
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL J STARKS in ABBOTT LABORATORIES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, STJ, ULGX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Grant | A | 0.00 | 1,499 | 0 | 7,021,898 | 7 M to 7 M (+0.02 %) | |
| Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 1,974 | 0 | 7,020,399 | 7 M to 7 M (+0.03 %) |
| Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 2,241 | 0 | 7,018,425 | 7 M to 7 M (+0.03 %) |
| May 01 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 2,945 | 0 | 7,016,184 | 7 M to 7 M (+0.04 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 400 | 24,348 | 7,013,239 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 107 | 6,513 | 7,012,839 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 1,200 | 73,032 | 7,012,732 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 293 | 17,831 | 7,011,532 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 1,000 | 60,850 | 7,011,239 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 100 | 6,085 | 7,010,239 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.84 | 1,000 | 60,840 | 7,010,139 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.83 | 600 | 36,498 | 7,009,139 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 200 | 12,164 | 7,008,539 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 400 | 24,326 | 7,008,339 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 900 | 54,729 | 7,007,939 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 100 | 6,081 | 7,007,039 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 400 | 24,320 | 7,006,939 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 300 | 18,239 | 7,006,539 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 800 | 48,632 | 7,006,239 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 400 | 24,314 | 7,005,439 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 2,100 | 127,638 | 7,005,039 | 7 M to 7 M (+0.03 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 200 | 12,155 | 7,002,939 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 2,100 | 127,617 | 7,002,739 | 7 M to 7 M (+0.03 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 600 | 36,459 | 7,000,639 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 2,500 | 151,900 | 7,000,039 | 7 M to 7 M (+0.04 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 175 | 10,632 | 6,997,539 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 2,200 | 133,650 | 6,997,364 | 7 M to 7 M (+0.03 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 1,100 | 66,820 | 6,995,164 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 200 | 12,149 | 6,994,064 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 2,000 | 121,480 | 6,993,864 | 7 M to 7 M (+0.03 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 400 | 24,294 | 6,991,864 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 2,200 | 133,606 | 6,991,464 | 7 M to 7 M (+0.03 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 1,079 | 65,522 | 6,989,264 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 4,900 | 297,528 | 6,988,185 | 7 M to 7 M (+0.07 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 1,317 | 79,962 | 6,983,285 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 100 | 6,071 | 6,981,968 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 8,100 | 491,751 | 6,981,868 | 7 M to 7 M (+0.12 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 700 | 42,494 | 6,973,768 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 4,800 | 291,360 | 6,973,068 | 7 M to 7 M (+0.07 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 500 | 30,348 | 6,968,268 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 4,400 | 267,036 | 6,967,768 | 7 M to 7 M (+0.06 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 487 | 29,554 | 6,963,368 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 4,500 | 273,060 | 6,962,881 | 7 M to 7 M (+0.06 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 103 | 6,250 | 6,958,381 | 7 M to 7 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 2,799 | 169,815 | 6,958,278 | 7 M to 7 M (+0.04 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 600 | 36,399 | 6,955,479 | 7 M to 7 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.66 | 1,600 | 97,056 | 6,954,879 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,600 | 97,040 | 6,953,279 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,500 | 90,968 | 6,951,679 | 7 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 1,300 | 78,832 | 6,950,179 | 6.9 M to 7 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 200 | 12,127 | 6,948,879 | 6.9 M to 6.9 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.63 | 700 | 42,441 | 6,948,679 | 6.9 M to 6.9 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.62 | 1,417 | 85,899 | 6,947,979 | 6.9 M to 6.9 M (+0.02 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 600 | 36,366 | 6,946,562 | 6.9 M to 6.9 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 14 | 848 | 6,945,962 | 6.9 M to 6.9 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 700 | 42,420 | 6,945,948 | 6.9 M to 6.9 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 100 | 6,060 | 6,945,248 | 6.9 M to 6.9 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.59 | 600 | 36,354 | 6,945,148 | 6.9 M to 6.9 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,548 | 6.9 M to 6.9 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,448 | 6.9 M to 6.9 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.57 | 400 | 24,228 | 6,944,348 | 6.9 M to 6.9 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.56 | 500 | 30,280 | 6,943,948 | 6.9 M to 6.9 M (+0.01 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.53 | 100 | 6,053 | 6,943,448 | 6.9 M to 6.9 M (0.00 %) |
| Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.52 | 100 | 6,052 | 6,943,348 | 6.9 M to 6.9 M (0.00 %) |
| Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Option Exercise | M | 33.14 | 336,131 | 11,139,381 | 0 | |
| Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Option Exercise | M | 28.50 | 168,413 | 4,799,771 | 0 | |
| Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | M | 33.14 | 336,131 | 11,139,381 | 6,943,248 | 6.6 M to 6.9 M (+5.09 %) |
| Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | M | 28.50 | 168,413 | 4,799,771 | 6,607,117 | 6.4 M to 6.6 M (+2.62 %) |
| Jul 06 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Payment of Exercise | F | 48.71 | 24,236 | 1,180,536 | 6,438,704 | 6.5 M to 6.4 M (-0.37 %) |
| May 02 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 3,437 | 0 | 6,462,940 | 6.5 M to 6.5 M (+0.05 %) |
Page: 1